metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology O- 23 STRATEGIES TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE AMERICAS
Información de la revista
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Acceso a texto completo
O- 23 STRATEGIES TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE AMERICAS
Visitas
315
Luis Antonio Díaz1, Sergio García1, Rayan Khan2, Gustavo Ayares1, Javier Uribe1, Francisco Idalsoaga1, José Miguel Fuentealba3, Eduardo Fuentes1, Katherine Maldonado4, Mariana Lazo5, Catterina Ferreccio1, Manuel Mendizabal6, Melisa Dirchwolf7, Patricia Guerra8, Claudia P. Oliveira9, Mario Guimarães9, Mario Reis10, Giada Sebastiani11, Mayur Brahmania12, Alnoor Ramji13..., Mina Niazi14, Hin Hin Ko13, Jordan Feld15, Juan Carlos Restrepo16, Wagner Ramírez17, Omar Alfaro18, Marlen Castellanos-Fernández19, Enrique Carrera20, José Roberto Aguirre Ayala21, Abel Sánchez4, Marco Sánchez22, María Teresa Andara23, Graciela Castro24, Norberto Chavez-Tapia25, Nahum Mendez-Sanchez25, Enrique Adames26, Julissa Lombardo27, Marcos Girala28, Elías Morán28, Martin Padilla-Machaca29, Javier Díaz30, Martín Tagle31, Victoria Mainardi32, Nelia Hernandez33, Edmundo Martínez34, Edilmar Alvarado-Tapias35, Roberto Leon36, Andrew Talal37, Emmanuel Thomas38, Sandra Springer39, Mauricio Garcia-Saenz-de-Sicilia40, Wei Zhang41, Jasmohan Bajaj42, Elliot B. Tapper43, Manhal J. Izzy44, Robert G. Gish45, Bashar Attar46, Thomas G. Cotter47, Michael R. Lucey48, Patrick S. Kamath49, Ashwani K. Singal50, Ramón Bataller51, Gabriel Mezzano52, Alejandro Soza1, Jeffrey V. Lazarus53, Marco Arrese1, Juan Pablo Arab2Ver más
1 Department of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile
2 Division of Gastroenterology, Department of Medicine, Western University & London Health Sciences Centre, Ontario, Canadá
3 Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile
4 Hospital Roosevelt, Ciudad de Guatemala, Guatemala
5 Dornsife School of Public Health, Philadelphia, Estados Unidos
6 Hospital Universitario Austral, Buenos Aires, Argentina
7 Hospital Privado de Rosario, Rosario, Argentina
8 Instituto de Gastroenterología Boliviano-Japonés, Cochabamba, Bolivia
9 University of Sao Paulo School of Medicine, Sao Paulo, Brasil
10 Hospital de Clínicas de Porto Alegre, Porto Alegre, Brasil
11 McGill University Health Centre, Quebec, Canadá
12 Univeristy of Calgary, Alberta, Canadá
13 University of British Columbia, British Columbia, Canadá
14 University of Saskatchewan, Saskatchewan, Canadá
15 Toronto General Hospital, Toronto, Ontario, Canadá
16 Hospital Pablo Tobon Uribe, Medellín, Colombia
17 Clínica Equilibrium, San José, Costa Rica
18 Hospital San Carlos, Ciudad Quesada, Costa Rica
19 University of Medical Sciences of Havana, Havana City, Cuba
20 Hospital Eugenio Espejo, Quito, Ecuador
21 Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador
22 Hospital Escuela Universitario, Tegucigalpa, Honduras
23 Instituto Hondureño de Seguridad Social, Tegucigalpa, Honduras
24 Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, México
25 Medica Sur Clinic & Foundation, Mexico City, México
26 Hospital Santo Tomas, Ciudad de Panamá, Panamá
27 Hospital Punta Pacífica, Ciudad de Panamá, Panamá
28 Universidad Nacional de Asunción, Asunción, Paraguay
29 Hospital Nacional Guillermo Almenara, Lima, Perú
30 Universidad Nacional Mayor de San Marcos, Lima, Perú
31 Clinica Anglo Americana, Lima, Perú
32 Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
33 Universidad de la República Uruguay, Montevideo, Uruguay
34 Hospital Dr. Sótero del Río, Santiago, Chile
35 Hospital de la Santa Creu i Sant Pau, Barcelona, España
36 Instituto Médico La Floresta, Caracas, Venezuela
37 University at Buffalo, New York, Estados Unidos
38 University of Miami Miller School of Medicine, Miami, Florida, Estados Unidos
39 Yale School of Medicine, New Haven, Connecticut, Estados Unidos
40 University of Arkansas for Medical Sciences, Arkansas, Estados Unidos
41 Massachusetts General Hospital, Boston, Massachusetts, Estados Unidos
42 Virginia Commonwealth University and Central Virginia Veterans Health Care System, Richmond, Virginia, Estados Unidos
43 University of Michigan, Ann Arbor, Michigan, Estados Unidos
44 Vanderbilt University Medical Center, Nashville, Tennessee, Estados Unidos
45 Loma Linda University, Loma Linda, California, Estados Unidos
46 Cook County Health, and Hospital Systems, Chicago, Illinois, Estados Unidos
47 UT Southwestern Medical Center, Dallas, Texas, Estados Unidos
48 University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, Estados Unidos
49 Mayo Clinic, Rochester, Minnesota, Estados Unidos
50 University of South Dakota Sanford School of Medicine, South Dakota, Estados Unidos
51 Liver Unit, Hospital Clinic, Barcelona, España
52 Universidad de Chile, Santiago, Chile
53 CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, Estados Unidos
Ver más
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S1

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Although the WHO strategy aims to eliminate the hepatitis C virus (HCV) as a public health threat by 2030, national strategies are variable worldwide. This study aimed to assess the establishment of different policies and strategies to eliminate HCV in the Americas.

Materials and Methods

We conducted a 23-item survey about HCV-related policies and strategies among gastroenterologists and hepatologists in the Americas. The survey was carried out electronically (2022–2023). Data were compared with governmental institutions, regulatory agencies, scientific societies, and scientific publications. We estimated an index obtained from a regression scoring method through exploratory analysis, and row values were normalized from 0 to 100.

Results

We obtained 52 responses from 19 countries. The median HCV-related policies index was 51.4 [IQR:27.3–70.1]. The lower establishment of HCV-related policies was observed in Ecuador (0.0), Honduras (6.6), and Costa Rica (9.8), while the highest performance was observed in Argentina (94.1), Colombia (94.7), and Canada (100)(Figure 1A). Fifteen (78.9%) countries have adopted a national strategic plan to eliminate HCV. Three (15.8%) countries have universal screening for HCV infection (Figure 1B). After a positive HCV serological test, 10 (52.6%) countries perform reflex testing to confirm HCV diagnosis using the same sample. However, only 7 (36.8%) countries have an alert system for the requesting physician. Twelve (63.2%) countries have a direct referral system for specialized care of HCV-positive cases. Universal access to direct-acting antivirals (DAAs) exists in 15 (78.9%) countries. Universal access to DAAs was not widely available in Cuba, Ecuador, Venezuela, and the United States. Seven (36.8%) countries have generic DAAs available. Only 3 (15.8%) countries performed a retrospective search for HCV-positive cases that could have been lost to follow-up.

Conclusions

Although most countries have adopted a national strategic plan to eliminate HCV, there are several issues and barriers to elimination in the Americas.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos